A multi-center population-based case–control study of ovarian cancer in African-American women: the African American Cancer Epidemiology Study (AACES)

作者: Joellen M Schildkraut , Anthony J Alberg , Elisa V Bandera , Jill Barnholtz-Sloan , Melissa Bondy

DOI: 10.1186/1471-2407-14-688

关键词:

摘要: Ovarian cancer (OVCA) is the leading cause of death from gynecological cancer, with poorer survival for African American (AA) women compared to whites. However, little known about risk factors OVCA in AA. To study epidemiology this population, we started a collaborative effort 10 sites US. Here describe and highlight challenges conducting lethal disease minority population. The Cancer Epidemiology Study (AACES) an ongoing, population-based case–control AA geographic locations, aiming recruit 850 invasive epithelial controls age- geographically-matched cases. Rapid case ascertainment random-digit-dialing systems are place ascertain cases controls, respectively. A telephone survey focuses on as well particular relevance AAs. Food-frequency questionnaires, follow-up surveys, biospecimens medical records also obtained. Current accrual 403 639 exceeds that any existing date. We observed high proportion (15%) deceased non-responders among part explained by advanced stage at diagnosis. logistic regression model did not support socio-economic status was factor Most associations were expected direction magnitude. High BMI associated ovarian risk, multivariable adjusted ORs 95% CIs 1.50 (0.99-2.27) obese 1.27 (0.85- 1.91) morbidly normal/underweight women. AACES targets rare tumor AAs addresses issues most relevant importance accentuated ascertained deceased. Our analyses indicated obesity, highly prevalent population (>60% cases), increased risk. While these findings need be replicated, they suggest potential effective intervention Upon completion enrollment, will largest epidemiologic

参考文章(22)
Kenneth J. Rothman, Sander Greenland, Timothy L. Lash, Case–Control Studies Encyclopedia of Quantitative Risk Analysis and Assessment. ,(2008) , 10.1002/9780470061596.RISK0599
Joellen M. Schildkraut, W. Douglas Thompson, G. P. Vogler, D. C. Rao, Relationship of epithelial ovarian cancer to other malignancies within families. Genetic Epidemiology. ,vol. 5, pp. 355- 367 ,(1988) , 10.1002/GEPI.1370050506
Catherine C. Boring, Cancer Statistics for African Americans CA: A Cancer Journal for Clinicians. ,vol. 52, pp. 326- 341 ,(1992) , 10.3322/CANJCLIN.42.1.7
P. G. Moorman, R. T. Palmieri, L. Akushevich, A. Berchuck, J. M. Schildkraut, Ovarian Cancer Risk Factors in African-American and White Women American Journal of Epidemiology. ,vol. 170, pp. 598- 606 ,(2009) , 10.1093/AJE/KWP176
John H. Farley, Chunqiao Tian, G. Scott Rose, Carol L. Brown, Michael Birrer, G. Larry Maxwell, Race Does Not Impact Outcome for Advanced Ovarian Cancer Patients Treated With Cisplatin/Paclitaxel: An Analysis of Gynecologic Oncology Group Trials Cancer. ,vol. 115, pp. 4210- 4217 ,(2009) , 10.1002/CNCR.24482
Jill S. Barnholtz-Sloan, Michael A. Tainsky, Judith Abrams, Richard K. Severson, Faisal Qureshi, Suzanne M. Jacques, Nancy Levin, Ann G. Schwartz, Ethnic differences in survival among women with ovarian carcinoma. Cancer. ,vol. 94, pp. 1886- 1893 ,(2002) , 10.1002/CNCR.10415
Esther M. John, Alice S. Whittemore, Robin Harris, Jacqueline Itnyre, , Characteristics Relating to Ovarian Cancer Risk: Collaborative Analysis of Seven U.S. Case-Control Studies. Epithelial Ovarian Cancer in Black Women Journal of the National Cancer Institute. ,vol. 85, pp. 142- 147 ,(1993) , 10.1093/JNCI/85.2.142
Sandro Galea, Melissa Tracy, Participation Rates in Epidemiologic Studies Annals of Epidemiology. ,vol. 17, pp. 643- 653 ,(2007) , 10.1016/J.ANNEPIDEM.2007.03.013
Carol DeSantis, Deepa Naishadham, Ahmedin Jemal, None, Cancer statistics for African Americans, 2013 CA: A Cancer Journal for Clinicians. ,vol. 63, pp. 151- 166 ,(2013) , 10.3322/CAAC.21173
Mishka Terplan, Nicholas Schluterman, Erica J. McNamara, J. Kathleen Tracy, Sarah M. Temkin, Have racial disparities in ovarian cancer increased over time? An analysis of SEER data Gynecologic Oncology. ,vol. 125, pp. 19- 24 ,(2012) , 10.1016/J.YGYNO.2011.11.025